Skip to main content

Decline of PD-L1 Immunoreactivity with Storage Duration in Formalin-Fixed Paraffin-Embedded Breast Cancer Specimens: Implications for Diagnostic Accuracy and Immunotherapy Eligibility in Triple-Negative Breast Cancer.

Yanagihara K, Nagata K, Yoshida M, Kato S, Tamura M, Yamakawa T

Publication: Cancers (2025) • Vol 17PMID: 41097632View on PubMed

Purpose

This paper compared PD-L1 immunohistochemical (IHC) staining in formalin-fixed, paraffin-embedded (FFPE) triple-negative breast cancer (TNBC) specimens at diagnosis and after storage of the FFPE block at room temperature for <1, 1-2, 2-3, or ≥3 years. The same antibody and staining kit (PD-L1 IHC 22C3 pharmDx) were used to stain sections during diagnosis and in fresh sections obtained after block storage.

Conclusion

At initial diagnosis, the PD-L1 status was negative in 22 (34.9%) and positive in 41 (65.1%) of the 63 cases evaluated with FFPE specimens. There was a significant association between FFPE block storage duration and declines in PD-L1 staining (P=0.015). While PD-L1 staining was unaffected by FFPE block storage in PD-L1 negative specimens, 7 of the 41 (17%) PD-L1 positive specimens had decreased staining after storage. When stratified by storage duration, decreased PD-L1 staining was found in 0 of the 8 specimens stored for < 1 year (0%), 1 of the 9 specimens stored for 1-2 years (11%), 2 of the 16 specimens stored for 2-3 years (13%), and 4 of the 8 specimens stored for ≥3 years (50%).

Studies (1)

Purpose

This study compared PD-L1 IHC staining in FFPE triple-negative breast cancer (TNBC) specimens at diagnosis and after storage of the FFPE block at room temperature for <1, 1-2, 2-3, or ≥3 years. The same antibody and staining kit (PD-L1 IHC 22C3 pharmDx) were used to stain sections during diagnosis and in fresh sections obtained after FFPE block storage. Core needle biopsies or surgical resection specimens from 63 patients with TNBC were fixed in 10% neutral buffered formalin for 10–72 h and embedded in paraffin. FFPE sections (4 µm) were stained using the PD-L1 IHC 22C3 pharmDx Kit using the Dako Autostainer Link 48 instrument and using the EnVision FLEX Target Retrieval Solution (Low pH) for antigen retrieval at diagnosis and again after storage at room temperature for <1 (10 cases), 1-2 (11 cases), 2-3 (25 cases), or ≥3 years (17 cases). PD-L1 positive immunostaining was defined as immunopositive staining of >10% of tumor cells for PD-L1.

Summary of Findings

At initial diagnosis, the PD-L1 status was negative in 22 (34.9%) and positive in 41 (65.1%) of the 63 cases evaluated with FFPE specimens. There was a significant association between FFPE block storage duration and declines in PD-L1 staining (P=0.015). While PD-L1 staining was unaffected by FFPE block storage in PD-L1 negative specimens, 7 of the 41 (17%) PD-L1 positive specimens had decreased staining after storage. When stratified by storage duration, decreased PD-L1 staining was found in 0 of the 8 specimens stored for < 1 year (0%), 1 of the 9 specimens stored for 1-2 years (11%), 2 of the 16 specimens stored for 2-3 years (13%), and 4 of the 8 specimens stored for ≥3 years (50%).

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageStorage duration
    1-2 years
    2-3 years
    < 1 year
    None
    ≥3 years